Figure 2. Survival curves of NY-ESO-1 antibody-positive and -negative patients.
The cumulative survival rate was calculated in iCCA patients with stage I + II (A) and stage III + IV (B) disease.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.